A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility
Affiliations
- PMID: 32861507
- DOI: 10.1016/j.bja.2020.07.042
Abstract
Background: Malignant hyperthermia (MH) susceptibility is an inherited condition, diagnosed either by the presence of a pathogenic genetic variant or by in vitro caffeine-halothane contracture testing. Through a multi-dimensional approach, we describe the implications of discordance between genetic and in vitro test results in a patient with a family history of possible MH.
Methods: The patient, whose brother had a possible MH reaction, underwent the caffeine-halothane contracture test (CHCT) according to the North American MH Group protocol. Screening of the complete RYR1 and CACNA1S transcripts was done using Sanger sequencing. Additional functional analyses included skinned myofibre calcium-induced calcium release sensitivity, calcium signalling assays in cultured myotubes, and in silico evaluation of the effect of any genetic variants on their chemical environment.
Results: The patient's CHCT result was negative but she carried an RYR1 variant c.1209C>G, p.Ile403Met, that is listed as pathogenic by the European Malignant Hyperthermia Group. Functional tests indicated a gain-of-function effect with a weak impact, and the variant was predicted to affect the folding stability of the 3D structure of the RyR1 protein. Based on American College of Medical Genetics and Genomics/Association of Molecular Pathology guidelines, this variant would be characterised as a variant of uncertain significance.
Conclusions: Available data do not confirm or exclude an increased risk of MH for this patient. Further research is needed to correlate RyR1 functional assays, including the current gold standard testing for MH susceptibility, with clinical phenotypes. The pathogenicity of genetic variants associated with MH susceptibility should be re-evaluated.
Keywords: ACMG/AMP guidelines; RYR1 variants; functional testing; malignant hyperthermia; phenotype–genotype discordance.
Copyright © 2020 British Journal of Anaesthesia. All rights reserved.
Similar articles
- Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.Anesthesiology. 1996 Feb;84(2):322-9. doi: 10.1097/00000542-199602000-00009.PMID: 8602662
- Malignant Hyperthermia Susceptibility.2003 Dec 19 [updated 2020 Jan 16]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 20301325 Free Books & Documents. Review.
- Genetic epidemiology of malignant hyperthermia in the UK.Br J Anaesth. 2018 Oct;121(4):944-952. doi: 10.1016/j.bja.2018.06.028. Epub 2018 Aug 17.PMID: 30236257 Free PMC article.
- Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.Anesth Analg. 2013 May;116(5):1078-86. doi: 10.1213/ANE.0b013e31828a71ff. Epub 2013 Apr 4.PMID: 23558838 Free PMC article.
- DNA testing for malignant hyperthermia: the reality and the dream.Anesth Analg. 2014 Feb;118(2):397-406. doi: 10.1213/ANE.0000000000000063.PMID: 24445638 Review.
No hay comentarios:
Publicar un comentario